Fludarabine-treosulfan compared to thiotepa-busulfan-fludarabine or FLAMSA as conditioning regimen for patients with primary refractory or relapsed acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
暂无分享,去创建一个
H. Einsele | N. Kröger | M. Labopin | A. Nagler | M. Mohty | D. Niederwieser | T. Bochtler | D. Bunjes | B. Savani | M. Eder | D. Beelen | A. Brecht | J. Tischer | H. Labussière-Wallet | F. Saraceni